For the quarter ending 2026-03-31, BCLI has $755K in assets. $11,764K in debts. $15K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 15 | 29 | 5 | 824 |
| Other long-term assets | - | 25 | 872 | 1,051 |
| Other accounts receivable | 122 | 86 | 80 | 106 |
| Prepaid expenses and other current assets | 47 | 192 | 423 | 585 |
| Total current assets | 184 | 307 | 508 | 1,515 |
| Prepaid expenses and other long-term assets | 25 | - | 24 | 24 |
| Restricted cash | 191 | 247 | 231 | 201 |
| Right of use asset (note 3) | 157 | 208 | 334 | 495 |
| Cost | - | 3,437 | - | - |
| Accumulated depreciation | - | 3,202 | - | - |
| Property and equipment, net | 198 | 235 | 283 | 331 |
| Total long-term assets | 571 | 715 | - | - |
| Total assets | 755 | 1,022 | 1,380 | 2,566 |
| Warrants liability (note 4) | - | - | - | 0 |
| Operating lease liability (note 3) | - | - | 50 | 95 |
| Accounts payable | 7,317 | 7,067 | 6,420 | 5,997 |
| Total long-term liabilities | - | - | 50 | 95 |
| Accrued expenses | 414 | 396 | 350 | 367 |
| Short-term loans (note 6) | 1,329 | 967 | 101 | 101 |
| Operating lease liability (note 3) | 159 | 208 | 276 | 381 |
| Employees related liability | 2,545 | 2,369 | 1,876 | 1,682 |
| Total current liabilities | 11,764 | 11,007 | 9,023 | 8,528 |
| Total liabilities | 11,764 | 11,007 | 9,073 | 8,623 |
| Common stock 0.00005 par value 250,000,000 shares authorized and 11,034,775 shares issued and outstanding | 16 | 16 | 16 | - |
| Additional paid-in-capital | 228,161 | 227,058 | 226,916 | 226,446 |
| Treasury stock | 116 | 116 | 116 | 116 |
| Accumulated deficit | -239,070 | -236,943 | -234,509 | - |
| Total stockholders' deficit | -11,009 | -9,985 | -7,693 | -6,057 |
| Total liabilities and stockholders' deficit | 755 | 1,022 | 1,380 | 2,566 |
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)